Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Motus GI Holdings Inc MOTS

Technology Scientific & Technical Instruments
Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI... see more

Recent & Breaking News (GREY:MOTS)

Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire May 14, 2024

Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 18, 2024

Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds

GlobeNewswire February 22, 2024

Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract

GlobeNewswire February 21, 2024

Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders

GlobeNewswire February 16, 2024

Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation

GlobeNewswire January 30, 2024

 Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering

GlobeNewswire December 18, 2023

Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 13, 2023

Motus GI Announces First Upper GI Patient Procedure for FDA Cleared Pure-Vu® EVS Gastro

GlobeNewswire November 10, 2023

Motus GI Announces 1-for-15 Reverse Stock Split

GlobeNewswire November 1, 2023

Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon

GlobeNewswire October 24, 2023

Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon

GlobeNewswire September 26, 2023

Motus GI Amends Royalty Agreement

GlobeNewswire September 14, 2023

Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors

GlobeNewswire September 6, 2023

Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire August 24, 2023

Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 14, 2023

Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System

GlobeNewswire August 10, 2023

Motus GI Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center

GlobeNewswire July 20, 2023

Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center

GlobeNewswire June 14, 2023

Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer

GlobeNewswire June 7, 2023